Injectable Drug Delivery Devices Market Research Report: Information by Devices (Conventional Injection Devices and Self-Injection Devices), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders and Cancer), Usage Pattern (Curative pattern and Immunization), Site of Delivery (Intramuscular, Subcutaneous and Intra Dermal), Distribution Channel (Hospital & Retail Pharmacies and Online Platforms), Facility of Use (Hospitals and Clinics and Home Care Settings) and Region (Americas, Europe, Asia-Pacific and Middle East & A...
ID: MRFR/MED/0704-CR | August 2019 | Region: Global | 164 Pages
1 Report Prologue
2 Market Introduction
2.1 Scope of Study 20
2.2 Research Objective 20
2.3 List of Assumptions 20
3 Research Methodology
3.1 Research Process 23
3.2 Primary Research 24
3.3 Secondary Research 25
3.4 Market Size Estimation 26
4 Market Dynamics
4.1 Introduction 28
4.2 Drivers 29
4.2.1 Increasing Prevalence of Chronic Diseases 29
4.2.2 Growing Adoption of Self-Injectable Devices 29
4.2.3 Rising FDA Approvals 29
4.2.4 Drivers Impact Analysis 30
4.3 Restraints 30
4.3.1 Risks of Cross-Contamination 30
4.3.2 Increasing Cost of High-End Products 30
4.3.3 Restraints Impact Analysis 31
4.4 Opportunity 31
4.4.1 Increasing Campaigns of Vaccination in Developing Economies of the Asia-Pacific Region 31
4.5 Macroeconomic Indicators 31
4.6 Market Trend 32
4.6.1 Increasing Use of Auto-Injectors Against Allergies 32
5 Market Factor Analysis
5.1 Value Chain Analysis 34
5.1.1 R&D and Designing 34
5.1.2 Manufacturing 34
5.1.3 Distribution & Sales 34
5.1.4 Post-Sales Review 35
5.2 Porter’s Five Forces Model 35
5.2.1 Threat of New Entrants 35
5.2.2 Bargaining Power of Suppliers 36
5.2.3 Threat of Substitutes 36
5.2.4 Bargaining Power of Buyers 36
5.2.5 Intensity of Rivalry 36
5.3 Investment Opportunities 36
5.4 Pricing Analysis 37
5.5 Demand & Supply: Gap Analysis 37
6 Injectable Drug Delivery Devices Market, by Devices
6.1 Introduction 39
6.2 Conventional Injection Devices 40
6.3 Self-Injection Devices 42
7 Injectable Drug Delivery Devices Market, by Therapeutic Application
7.1 Introduction 44
7.2 Autoimmune Diseases 45
7.3 Hormonal Disorders 45
7.4 Cancer 45
8 Injectable Drug Delivery Devices Market, by Usage Pattern
8.1 Introduction 47
8.2 Curative Pattern 48
8.3 Immunization 48
9 Injectable Drug Delivery Devices Market, by Site of Delivery
9.1 Introduction 50
9.2 Intramuscular 51
9.3 Subcutaneous 51
9.4 Intra Dermal 51
10 Injectable Drug Delivery Devices Market, by Distribution Channel
10.1 Introduction 53
10.2 Hospital & Retail Pharmacies 54
10.3 Online Platforms 54
11 Injectable Drug Delivery Devices Market, by Facility of Use
11.1 Introduction 56
11.2 Hospitals and Clinics 57
11.3 Home Care Settings 57
12 Global Injectable Drug Delivery Devices Market, by Region
12.1 Introduction 59
12.2 Americas 60
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.2.1 North America 63
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.2.1.1 US 66
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.2.1.2 Canada 68
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.2.1.3 South America 71
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.3 Europe 74
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.3.1 Western Europe 77
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.3.1.1 Germany 80
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.3.1.2 UK 83
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.3.1.3 France 86
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.3.1.4 Italy 88
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.3.1.5 Spain 91
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.3.1.6 Rest of Western Europe 94
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.3.2 Eastern Europe 97
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.4 Asia-Pacific 100
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.4.1 Japan 103
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.4.2 China 106
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.4.3 India 108
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.4.4 South Korea 111
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.4.5 Australia 114
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.4.6 Rest of Asia-Pacific 117
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.5 Middle East & Africa 120
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.5.1 Middle East 123
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
12.5.2 Africa 126
Injectable Drug Delivery Devices Market, by Devices
Injectable Drug Delivery Devices Market, by Therapeutic Application
Injectable Drug Delivery Devices Market, by Usage Pattern
Injectable Drug Delivery Devices Market, by Site of Delivery
Injectable Drug Delivery Devices Market, by Distribution Channel
Injectable Drug Delivery Devices Market, by Facility of Use
13 Competitive Landscape
13.1 Introduction 130
14 Company Profile
14.1 Eisai Co., Ltd. 132
14.1.1 Company Overview 132
14.1.2 Financial Overview 132
14.1.3 Products Offered 133
14.1.4 Key Developments 133
14.1.5 SWOT Analysis 133
14.1.6 Key Strategies 133
14.2 Antares Pharma 134
14.2.1 Company Overview 134
14.2.2 Financial Overview 134
14.2.3 Products Offered 135
14.2.4 Key Developments 135
14.2.5 SWOT Analysis 135
14.2.6 Key Strategies 135
14.3 AstraZeneca 136
14.3.1 Company Overview 136
14.3.2 Financial Overview 136
14.3.3 Pipeline Products 137
14.3.4 Key Developments 137
14.3.5 SWOT Analysis 137
14.3.6 Key Strategies 137
14.4 Becton, Dickinson and Company 138
14.4.1 Company Overview 138
14.4.2 Financial Overview 138
14.4.3 Products Offered 139
14.4.4 Key Developments 139
14.4.5 SWOT Analysis 140
14.4.6 Key Strategies 140
14.5 Eli Lilly and Company 141
14.5.1 Company Overview 141
14.5.2 Financial Overview 141
14.5.3 Products Offered 142
14.5.4 Key Developments 142
14.5.5 SWOT Analysis 142
14.5.6 Key Strategies 142
14.6 F. Hoffmann-La Roche AG 143
14.6.1 Company Overview 143
14.6.2 Financial Overview 143
14.6.3 Products Offered 144
14.6.4 Key Developments 144
14.6.5 SWOT Analysis 144
14.6.6 Key Strategies 144
14.7 Johnson & Johnson Services Inc. 145
14.7.1 Company Overview 145
14.7.2 Financial Overview 145
14.7.3 Products Offered 146
14.7.4 Key Developments 146
14.7.5 SWOT Analysis 146
14.7.6 Key Strategies 146
14.8 Mylan N.V. 147
14.8.1 Company Overview 147
14.8.2 Financial Overview 147
14.8.3 Products Offered 148
14.8.4 Key Developments 148
14.8.5 SWOT Analysis 148
14.8.6 Key Strategies 148
14.9 Novartis AG 149
14.9.1 Company Overview 149
14.9.2 Financial Overview 149
14.9.3 Products Offered 150
14.9.4 Key Developments 150
14.9.5 SWOT Analysis 150
14.9.6 Key Strategies 150
14.10 Novo Nordisk 151
14.10.1 Company Overview 151
14.10.2 Financial Overview 151
14.10.3 Products Offered 152
14.10.4 Key Developments 152
14.10.5 SWOT Analysis 152
14.10.6 Key Strategies 152
14.11 Pfizer Inc. 153
14.11.1 Company Overview 153
14.11.2 Financial Overview 153
14.11.3 Products Offered 154
14.11.4 Key Developments 154
14.11.5 SWOT Analysis 154
14.11.6 Key Strategies 154
14.12 Sanofi 155
14.12.1 Company Overview 155
14.12.2 Financial Overview 155
14.12.3 Products Offered 156
14.12.4 Key Developments 156
14.12.5 SWOT Analysis 156
14.12.6 Key Strategies 156
14.13 Teva Pharmaceutical Industries Ltd 157
14.13.1 Company Overview 157
14.13.2 Financial Overview 157
14.13.3 Products Offered 158
14.13.4 Key Developments 158
14.13.5 SWOT Analysis 158
14.13.6 Key Strategies 158
14.14 Inovio Pharmaceuticals Inc. 159
14.14.1 Company Overview 159
14.14.2 Financial Overview 159
14.14.3 Products Offered 160
14.14.4 Key Developments 160
14.14.5 SWOT Analysis 160
14.14.6 Key Strategies 160
15 Appendix
15.1 Discussion Blue Print 162
16 List of Tables
TABLE 1 LIST OF ASSUMPTIONS 20
TABLE 2 PRIMARY INTERVIEWS 24
TABLE 3 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 39
TABLE 4 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR CONVENTIONAL INJECTION DEVICES BY REGION 2020–2027 (USD MILLION) 40
TABLE 5 GLOBAL CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 40
TABLE 6 GLOBAL CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 41
TABLE 7 GLOBAL CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 41
TABLE 8 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR SELF-INJECTION DEVICES BY REGION 2020–2027 (USD MILLION) 42
TABLE 9 GLOBAL SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 42
TABLE 10 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020–2027 (USD MILLION) 44
TABLE 11 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR AUTOIMMUNE DISEASES BY REGION 2020–2027 (USD MILLION) 45
TABLE 12 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HORMONAL DISORDERS BY REGION 2020–2027 (USD MILLION) 45
TABLE 13 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR CANCER BY REGION 2020–2027 (USD MILLION) 45
TABLE 14 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 47
TABLE 15 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR CURATIVE PATTERN BY REGION 2020–2027 (USD MILLION) 48
TABLE 16 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR IMMUNIZATION BY REGION 2020–2027 (USD MILLION) 48
TABLE 17 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 50
TABLE 18 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR INTRAMUSCULAR BY REGION 2020–2027 (USD MILLION) 51
TABLE 19 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR SUBCUTANEOUS BY REGION 2020–2027 (USD MILLION) 51
TABLE 20 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR INTRA DERMAL BY REGION 2020–2027 (USD MILLION) 51
TABLE 21 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 53
TABLE 22 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HOSPITAL & RETAIL PHARMACIES BY REGION 2020–2027 (USD MILLION) 54
TABLE 23 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR ONLINE PLATFORMS BY REGION 2020–2027 (USD MILLION) 54
TABLE 24 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 56
TABLE 25 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HOSPITALS AND CLINICS BY REGION 2020–2027 (USD MILLION) 57
TABLE 26 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HOME CARE SETTINGS BY REGION 2020–2027 (USD MILLION) 57
TABLE 27 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY REGION 2020–2027 (USD MILLION) 59
TABLE 28 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY REGION 2020–2027 (USD MILLION) 60
TABLE 29 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 60
TABLE 30 AMERICAS SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 61
TABLE 31 AMERICAS CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 61
TABLE 32 AMERICAS CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 61
TABLE 33 AMERICAS CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 61
TABLE 34 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 62
TABLE 35 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 62
TABLE 36 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 62
TABLE 37 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 62
TABLE 38 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 63
TABLE 39 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 63
TABLE 40 NORTH AMERICA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 63
TABLE 41 NORTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 63
TABLE 42 NORTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 64
TABLE 43 NORTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 64
TABLE 44 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 64
TABLE 45 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 64
TABLE 46 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 65
TABLE 47 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 65
TABLE 48 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 65
TABLE 49 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 66
TABLE 50 US SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 66
TABLE 51 US CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 66
TABLE 52 US CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 66
TABLE 53 US CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 67
TABLE 54 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 67
TABLE 55 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 67
TABLE 56 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 67
TABLE 57 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 68
TABLE 58 US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 68
TABLE 59 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 68
TABLE 60 CANADA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 68
TABLE 61 CANADA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 69
TABLE 62 CANADA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 69
TABLE 63 CANADA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 69
TABLE 64 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 69
TABLE 65 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 70
TABLE 66 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 70
TABLE 67 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 70
TABLE 68 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 71
TABLE 69 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 71
TABLE 70 SOUTH AMERICA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 71
TABLE 71 SOUTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 71
TABLE 72 SOUTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 72
TABLE 73 SOUTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 72
TABLE 74 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 72
TABLE 75 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 72
TABLE 76 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 73
TABLE 77 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 73
TABLE 78 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 73
TABLE 79 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY REGION 2020–2027 (USD MILLION) 74
TABLE 80 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 74
TABLE 81 EUROPE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 75
TABLE 82 EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 75
TABLE 83 EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 75
TABLE 84 EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 75
TABLE 85 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 76
TABLE 86 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 76
TABLE 87 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 76
TABLE 88 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 76
TABLE 89 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 77
TABLE 90 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY 2020–2027 (USD MILLION) 77
TABLE 91 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 77
TABLE 92 WESTERN EUROPE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 78
TABLE 93 WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 78
TABLE 94 WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 78
TABLE 95 WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 78
TABLE 96 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 79
TABLE 97 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 79
TABLE 98 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 79
TABLE 99 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 80
TABLE 100 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 80
TABLE 101 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 80
TABLE 102 GERMANY SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 80
TABLE 103 GERMANY CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 81
TABLE 104 GERMANY CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 81
TABLE 105 GERMANY CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 81
TABLE 106 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 81
TABLE 107 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 82
TABLE 108 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 82
TABLE 109 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 82
TABLE 110 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 83
TABLE 111 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 83
TABLE 112 UK SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 83
TABLE 113 UK CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 83
TABLE 114 UK CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 84
TABLE 115 UK CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 84
TABLE 116 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 84
TABLE 117 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 84
TABLE 118 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 85
TABLE 119 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 85
TABLE 120 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 85
TABLE 121 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 86
TABLE 122 FRANCE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 86
TABLE 123 FRANCE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 86
TABLE 124 FRANCE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 86
TABLE 125 FRANCE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 87
TABLE 126 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 87
TABLE 127 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 87
TABLE 128 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 87
TABLE 129 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 88
TABLE 130 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 88
TABLE 131 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 88
TABLE 132 ITALY SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 88
TABLE 133 ITALY CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 89
TABLE 134 ITALY CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 89
TABLE 135 ITALY CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 89
TABLE 136 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 89
TABLE 137 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 90
TABLE 138 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 90
TABLE 139 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 90
TABLE 140 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 91
TABLE 141 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 91
TABLE 142 SPAIN SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 91
TABLE 143 SPAIN CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 91
TABLE 144 SPAIN CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 92
TABLE 145 SPAIN CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 92
TABLE 146 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 92
TABLE 147 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 92
TABLE 148 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 93
TABLE 149 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 93
TABLE 150 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 93
TABLE 151 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 94
TABLE 152 REST OF WESTERN EUROPE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 94
TABLE 153 REST OF WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 94
TABLE 154 REST OF WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 94
TABLE 155 REST OF WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 95
TABLE 156 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 95
TABLE 157 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 95
TABLE 158 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 96
TABLE 159 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 96
TABLE 160 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 96
TABLE 161 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 97
TABLE 162 EASTERN EUROPE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 97
TABLE 163 EASTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 97
TABLE 164 EASTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 97
TABLE 165 EASTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 98
TABLE 166 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 98
TABLE 167 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 98
TABLE 168 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 99
TABLE 169 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 99
TABLE 170 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 99
TABLE 171 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY 2020–2027 (USD MILLION) 100
TABLE 172 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 100
TABLE 173 ASIA-PACIFIC SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 101
TABLE 174 ASIA-PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 101
TABLE 175 ASIA-PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 101
TABLE 176 ASIA-PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 101
TABLE 177 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 102
TABLE 178 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 102
TABLE 179 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 102
TABLE 180 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 102
TABLE 181 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 103
TABLE 182 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 103
TABLE 183 JAPAN SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 103
TABLE 184 JAPAN CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 103
TABLE 185 JAPAN CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 104
TABLE 186 JAPAN CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 104
TABLE 187 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 104
TABLE 188 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 104
TABLE 189 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 105
TABLE 190 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 105
TABLE 191 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 105
TABLE 192 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 106
TABLE 193 CHINA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 106
TABLE 194 CHINA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 106
TABLE 195 CHINA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 106
TABLE 196 CHINA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 107
TABLE 197 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 107
TABLE 198 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 107
TABLE 199 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 107
TABLE 200 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 108
TABLE 201 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 108
TABLE 202 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 108
TABLE 203 INDIA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 108
TABLE 204 INDIA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 109
TABLE 205 INDIA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 109
TABLE 206 INDIA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 109
TABLE 207 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 109
TABLE 208 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 110
TABLE 209 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 110
TABLE 210 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 110
TABLE 211 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 111
TABLE 212 SOUTH KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 111
TABLE 213 SOUTH KOREA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 111
TABLE 214 SOUTH KOREA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 111
TABLE 215 SOUTH KOREA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 112
TABLE 216 SOUTH KOREA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 112
TABLE 217 SOUTH KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 112
TABLE 218 SOUTH KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 112
TABLE 219 SOUTH KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 113
TABLE 220 SOUTH KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 113
TABLE 221 SOUTH KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 113
TABLE 222 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 114
TABLE 223 AUSTRALIA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 114
TABLE 224 AUSTRALIA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 114
TABLE 225 AUSTRALIA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 114
TABLE 226 AUSTRALIA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 115
TABLE 227 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 115
TABLE 228 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 115
TABLE 229 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 116
TABLE 230 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 116
TABLE 231 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 116
TABLE 232 REST OF ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 117
TABLE 233 REST OF ASIA-PACIFIC SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 117
TABLE 234 REST OF ASIA-PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 117
TABLE 235 REST OF ASIA-PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 117
TABLE 236 REST OF ASIA-PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 118
TABLE 237 REST OF ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 118
TABLE 238 REST OF ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 118
TABLE 239 REST OF ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 119
TABLE 240 REST OF ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 119
TABLE 241 REST OF ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 119
TABLE 242 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY REGION 2020–2027 (USD MILLION) 120
TABLE 243 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 120
TABLE 244 MIDDLE EAST & AFRICA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 121
TABLE 245 MIDDLE EAST & AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 121
TABLE 246 MIDDLE EAST & AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 121
TABLE 247 MIDDLE EAST & AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 121
TABLE 248 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 122
TABLE 249 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 122
TABLE 250 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 122
TABLE 251 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 123
TABLE 252 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 123
TABLE 253 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 123
TABLE 254 MIDDLE EAST SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 123
TABLE 255 MIDDLE EAST CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 124
TABLE 256 MIDDLE EAST CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 124
TABLE 257 MIDDLE EAST CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 124
TABLE 258 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 124
TABLE 259 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 125
TABLE 260 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 125
TABLE 261 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 125
TABLE 262 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 126
TABLE 263 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 126
TABLE 264 AFRICA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 126
TABLE 265 AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 126
TABLE 266 AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 127
TABLE 267 AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 127
TABLE 268 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 127
TABLE 269 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 127
TABLE 270 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 128
TABLE 271 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 128
TABLE 272 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 128
TABLE 273 TOP PLAYERS IN THE GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET 130
17 List of Figures
FIGURE 1 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET: MARKET STRUCTURE 21
FIGURE 2 RESEARCH PROCESS 23
FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACH 26
FIGURE 4 MARKET DYNAMICS: GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET 28
FIGURE 5 DRIVERS IMPACT ANALYSIS: GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET 30
FIGURE 6 RESTRAINTS IMPACT ANALYSIS: GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET 31
FIGURE 7 VALUE CHAIN: GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET 34
FIGURE 8 PORTER’S FIVE FORCES MODEL: GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET 35
FIGURE 9 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020 & 2027 (USD MILLION) 40
FIGURE 10 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 44
FIGURE 11 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020 & 2027 (USD MILLION) 47
FIGURE 12 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020 & 2027 (USD MILLION) 50
FIGURE 13 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020 & 2027 (USD MILLION) 53
FIGURE 14 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020 & 2027 (USD MILLION) 56
FIGURE 15 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET SHARE, BY REGION 2020 (%) 59
FIGURE 16 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET SHARE, BY REGION 2020 (%) 60
FIGURE 17 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET SHARE, BY REGION 2020 (%) 74
FIGURE 18 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 100
FIGURE 19 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET SHARE, BY REGION 2020 (%) 120
Injectable Drug Delivery Devices Market
The injectable drug delivery devices market will rise with a CAGR of 11.60% CAGR. It is anticipated to touch the total worth of USD 37,811.06 million by the year 2030
$37,811.06 Million
Market Size
11.60%
CAGR
North America
Dominating Region
2020-2030
Forecast Period
Segmentation
Key Players
- Eisai Co. Ltd
- Antares Pharma
- AstraZeneca
- Becton
- Dickinson and Company
- Eli Lilly and Company
- Hoffmann-La Roche AG
- Johnson & Johnson Services Inc.
- Mylan N.V.
- Novartis AG
Drivers
- Growing numbers of infectious and chronic diseases
- Self-Injection market and healthcare industry run corollary to each other
Injectable Drug Delivery Devices Market Overview
The injectable drug delivery devices market will rise with a CAGR of 11.60% CAGR. It is anticipated to touch the total worth of USD 37,811.06 million by the year 2030. Injectable devices are used to deliver and transport a medicinal drug to the body of a patient. Injectable drug delivery equipment is available in vast verities, such as conventional syringes, needle-free injectors, auto-injectors, and pen injectors. Subcutaneous drug delivery devices are used in the treatment of many infectious as well as chronic diseases. In this, a syringe injects the medicinal drugs into the layer betwixt tissues and muscles. The absorption occurs at a slower rate than the direct injection into veins.
Injectable drug delivery devices market size is anticipated to increase at a faster rate in the coming future. It owns to the rise in the level of awareness among people and huge investments in medical infrastructure.
COVID-19 Analysis
Coronavirus is a highly infectious disease that is majorly attacking the respiratory system of people. People across the globe are suffering from the covid19. It has adversely affected the functioning of all the industries, except for the pharmaceutical industry. More ventilators, testing kits, medicinal drugs, vaccines, and oxygen cylinders are required than they were demanded before the global pandemic.
The injectable drug delivery devices industry saw a boom throughout the last year as there was a rise in the requirement of injectable devices and other healthcare products. The government of every nation is investing a huge chunk of its financial resources in procuring and manufacturing more medicinal drugs and medical equipment. People across the globe are getting vaccinated. This, in turn, is increasing the injectable drug delivery devices market growth.
Injectable Drug Delivery Devices Market Dynamics
Drivers
Self-Injection market and healthcare industry run corollary to each other. With the growing numbers of infectious and chronic diseases, such as cancer and TB, people are becoming more health-conscious. This gives a boost to the self-injection market, as self-injections can easily be used at home healthcare centers without needing any professional help.
Opportunities
The life expectancy has increased several folds which means that there is a large population of elderly people who are to be medically treated. The awareness among people also increases the demand for connected injectable drug delivery devices. The demand for disposal injecting devices and pre-filled syringes has increased. This owns to the elimination of vial and syringe devices as they were more prone to dosage errors and sterility problems.
Restraints
The advanced Injectable drug delivery devices are costly and few people cannot afford them. Many people do not want to use injectable drugs for curing their ailment. The rigid policies of medical authorities to provide standardized Injectable drug delivery devices may hinder the growth of the market globally.
Value Chain Analysis
Owing to an unhealthy lifestyle and deteriorating environment a need arises for more medical facilities. The key players in the market are making technological advances regularly to provide safe products to the customers. In the year 2017, American Diabetes Association published a report stating that 9.4% of the total population of the USA is diabetic. This will prompt the need for injectable devices, as insulin is injected directly in patients with high blood sugar levels. Easy-to-use self-injections are also gaining a lot of popularity these days.
Injectable Drug Delivery Devices Market Size, by Site of Delivery, 2017 & 2023 (USD Million) 
Source: MRFR Analysis
Injectable Drug Delivery Devices Market Segmentation
The global market of Injectable drug delivery devices can be divided into various segments. These are: based on devices, based on therapeutic application, based on usage pattern, based on site of delivery, and based on facility of use.
Based on devices
- Various devices available in the Injectable drug delivery devices market are as follows: Conventional Injectable, Prefilled Syringes, Auto-injectors, Pen-injectors, and self-injectors.
Based on application
- Injectable drug delivery devices are utilized in the treatment of various diseases, such as Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, and Others.
Based on the usage pattern
- Injectable can be used for two purposes: Curative pattern and immunization. Healing or treatment of any disease requires direct medicinal drug injection. Immunization injectable is boosters that are to be given regularly to a patient.
Based on site of delivery
- Injectable is applied at two levels: subcutaneous, and intradermal.
Based on the facility of use
- End-users of injectable drug delivery devices are Hospitals, Clinics, Home Healthcare Settings, Pharmaceutical & Biotechnological Companies, Research Laboratories, etc.
Global Injectable Drug Delivery Devices Market Share, by Region, 2017 (%) 
Source: MRFR Analysis
Injectable Drug Delivery Devices Market Regional Analysis
The medical device packaging market size is increasing with every passing day. It is leaving its impression in every corner of the world. The regions involved in Medical Device Packaging Market Analysis include America, Europe, Asia-pacific, and the rest of the world.
America, which includes the area of North America (the US and Canada) and Latin America, has the largest injectable drug delivery devices market share. This owns to rising awareness among people and heavy investment in the medical industry by the government. The total market worth of this region is expected to shoot up to USD 17,401.8 million by the year 2023.
The European region, which includes Germany, UK, France, Russia, and Italy, bagged the second position in the global market in the year 2017. This owns to the rise in Research & Development activities by the medical authorities.
Asia-Pacific region, which includes China, Japan, India, Australia, and South Korea, provides a huge market for both consumption as well as production of Injectable drug delivery devices. This is due to the availability of cheap resources, inexpensive labor, and a rise in population. The government of these nations is investing extensively in the medical infrastructure.
The rest of the world, which includes the region of the Middle East and Africa, is showing a constant but slow growth because of the limited resources with the government and lack of awareness among the general public.
Injectable Drug Delivery Devices Market Competitive Landscape
The list of major key players involved in data analysis of injectable drug delivery devices market trends is as follows:
- Eisai Co. Ltd
- Antares Pharma
- AstraZeneca
- Becton
- Dickinson and Company
- Eli Lilly and Company
- Hoffmann-La Roche AG
- Johnson & Johnson Services Inc.
- Mylan N.V.
- Novartis AG
- Novo Nordisk
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd
- Inovio Pharmaceuticals Inc.
The above-listed companies come together in joint ventures, mergers and, acquisitions to make new technical advances in injectable drug delivery devices technologies. Their main objective is to deliver products that are cost-effective, hassle-free in operations, and are of superior quality.
Recent Developments
Various developments that are found in Injectable drug delivery devices Market Outlook are as follows:
- HUMIRA Pen is an auto-injector that was produced by the joint efforts of AbbVie and Eisai Co. Ltd. in June of the year 2018. It was launched for curing arthritis and its variants.
- In August of the year 2018, Antares Pharma Co. formed an agreement with Pfizer Inc., over the production of a multi-utility auto-injector Quick shot.
- In December of the year 2017, Novo Nordisk produced a pre-filled syringe to treat diabetic patients. This injectable drug delivery device got approved by FDA for its effective quality and functioning.
- In November of the year 2017, west pharmaceutical services ltd. produced wearable injections. It was an extension of a pre-existing smart-dose drug.
- A subcutaneous injector was produced by Ever Neuro Pharma GMBH, in July of the year 2019. It was easy to use and can be used at home healthcare centers.
Report Overview
This market research report of Injectable drug delivery devices Market Trends includes the following elements:
- Market Overview
- COVID19 Analysis
- Market Dynamics
- Value Chain Analysis
- Market Segmentation
- Regional Analysis
- Competitive Landscape
- Recent Developments
This research report, on the global market of Injectable drug delivery devices, provides a thorough analysis of its application and its market trends. Injectable drug delivery equipment is available in vast verities, such as conventional syringes, needle-free injectors, auto-injectors, and pen injectors. The injectable drug delivery devices market will rise with a CAGR of 11.3% CAGR. Injectable drug delivery devices are utilized in the treatment of various diseases, such as Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, and Others.
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | USD 37,811.06 Million |
| CAGR | 11.60% (2020-2030) |
| Base Year | 2019 |
| Forecast Period | 2020-2030 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Devices, Therapeutic Application, Usage Pattern, Site of Delivery, Distribution Channel, Facility of Use and Region |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Eisai Co., Ltd, Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson Services Inc., Mylan N.V., Novartis AG, Novo Nordisk, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd, and Inovio Pharmaceuticals |
| Key Market Opportunities |
|
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Market Research Future predicts that Global Injectable Drug Delivery Devices Market is estimated to reach USD 37,811.06 Million by 2030
Eisai Co., Ltd, Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company, F. Hoffmann-La Roche AG
Global Injectable Drug Delivery Devices Market is expected to register a CAGR of 11.60% during forecast period upto 2030
Major factor contributing to the growth of the global Injectable Drug Delivery Devices Market is adoption of self-injectable devices, Rising FDA approvals for the drug delivery devices, and others.
The Americas is anticipated to dominate the global Injectable Drug Delivery Devices Market. This region is expected to reach USD 37,811.06 million by 2030 with a CAGR of 11.60% from 2020 to 2030
Global Injectable Drug Delivery Devices Market: Competitive Landscape
The Global Injectable Drug Delivery Devices Market is characterized by the presence of many global, regional, and local vendors. There are many large and small players are operating in the global injectable drug delivery devices market. The market is highly competitive with all the players competing to gain market share. Rising competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The manufacturers compete based on cost, quality, and reliability. It is decisive for the manufacturers to provide cost-efficient and high-quality products, to survive and succeed in an intensely competitive market environment. Some of the top players in this market are BD, Astra Zeneca, F. Hoffmann-La Roche AG, and Johnson & Johnson Services Inc which holds the significant market share.
BD is a medical device company, headquartered in US, the company is involved in providing laboratory equipment, and diagnostic products worldwide. BD develops and launches new products for various drug delivery devices. In September 2017, the company introduced BD Ultra-Fine Micro 6mm micro pen needle used by diabetic patients to inject insulin.
Astra Zeneca focuses on developing and commercializing prescribed medicines. The company majorly focuses on three main therapy areas, namely, cardiovascular and metabolic disease (CVMD), oncology, and respiratory. Astra Zeneca developments and launches new products globally to strength its market position. In August 2018 the company received approval from the European Commission for Bydureon BCise which an injectable drug delivery device is, for type-2 diabetic patients.
Hoffmann-La Roche AG a leading biotech company which operates globally that includes the regions North America, Europe, South America, Africa, and Asia-Oceania. The company is dedicated to developing innovative diagnostic tests and medicines to help patients across the world. In October 2016, the company received the US FDA approval for Lucentis (ranibizumab injection) a prefilled syringe, used for the treatment of eye problems.
Johnson & Johnson Services Inc involved in providing medical devices for orthopaedics, cardiovascular diseases, and many others. The company majorly focuses on mergers/acquisitions and developing various drug delivery devices to stronger their product portfolio. In July 2017 received the FDA approval for TREMFYA (GUSELKUMAB) a subcutaneous injection use for the treatment of plaque psoriasis.
The growth of injectable drug delivery devices market is dependent on the market conditions, government support, and industry development. Thus, the companies are focusing on expanding geographically, collaborations, product launches, mergers and acquisitions and improving their products.
Intended Audience:
- Medical Device Manufacturers
- Biotech Companies
- Suppliers and Distributors
- Governmental and Private Laboratories
- Research Institutes and Academic Centers
- Market Research and Consulting
- End-user sectors
